Multiple Manufacturers

ELIGARD

Manufacturer:

Multiple Manufacturers

Eligard HCPCS:

J9217

HCPCS Code Descriptor:

Leuprolide acetate (for depot suspension), 7.5 mg

Category:

J Code

Eligard NDCs:

00074-3575-01, 00074-3473-03, 00074-3683-03, 00074-3346-03, 62935-0461-50, 62935-0453-45, 00074-3642-03, 62935-0303-30, 62935-0223-05, 62935-0753-75

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

62935-0461-50, 62935-0303-30

About Eligard:

ELIGARD is an Oncology drug manufactured by Tolmar and administered via the Intramuscular route of administration. The J Code: J9217 is aligned to the drug ELIGARD.

Eligard is used to minimize the symptoms of certain cancers through hormone therapy. By initially causing the overproduction of certain hormones, Eligard causes the body to stop producing these select hormones all together. Eligard is a branded drug manufactured by Tolmar Pharmaceuticals. Patient assistance programs for Eligard can be found through Tolmar Pharmaceuticals.

ACCESS PRICING AND MORE BY REGISTERING

J9217 Added Date:

January 1, 1991

J9217 Effective Date:

January 1, 1997

J9217 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Eligard billing and coding information.
Eligard patient assistance information can be found through Tolmar Total Solutions at the URL: https://eligardhcp.com/coverage-reimbursement
ELIGARD prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ELIGARD. Please check back in a few weeks.